Percutaneous coronary intervention in Burkina Faso: About the first cases performed in Ouagadougou

Scritto il 07/10/2026
da Y Kambiré

Ann Cardiol Angeiol (Paris). 2026 Oct 7:S0003-3928(26)00099-5. doi: 10.1016/j.ancard.2026.102094. Online ahead of print.

ABSTRACT

BACKGROUND: Percutaneous coronary intervention (PCI) is a relatively new technique in Burkina Faso. Our objective was to describe the indications, and outcome of the first cases performed at the Tengandogo University Hospital in Ouagadougou.

METHODS: This was a descriptive cross-sectional study involving retrospective collection of available data and prospective follow-up of patients who underwent coronary angiography in order to benefit a PCI from March 22, 2022, to August 31, 2024, in the interventional cardiology unit of the Tengandogo University Hospital.

RESULTS: Sixty-three patients, with a mean age of 58.86±10.59 years, were included in the study, showing a male predominance (83%). The main cardiovascular risk factors among patients were hypertension (92.1%), age correlated with sex (79.4%), and a sedentary lifestyle (55.6%). ST-segment Elevation Myocardial Infarction was the primary indication (55.6%). Lesions were multivessel in 66.7% of cases. PCI by stenting was performed in 59 (93.7%) of patients. The PCI procedure was successful in 59 patients (93.7%). The in-hospital course was marked by four deaths, including one on the operating table due to critical ostial stenosis of the left main coronary artery.

CONCLUSION: Percutaneous coronary intervention is feasible in Burkina Faso despite numerous challenges. It improves the management of coronary artery disease.

PMID:42844063 | DOI:10.1016/j.ancard.2026.102094